Right. If you add the additional constraint that the total funding must stay even, I have to preface my answer, because I think it's difficult for me to really give a fair, unbiased answer.
As I mentioned before, our company is very heavily involved in very innovative front-end contract research and the SR&ED program has been very beneficial to us. Depending on how the reallocation occurred, I could potentially be persuaded.